Latest Varian Medical Systems Stories
Second quarter net earnings per diluted share are $0.88 including patent litigation settlement; revenues increase 1 percent to $779 million PALO ALTO, Calif., April 23, 2014 /PRNewswire/
More than 1,500 oncology professionals hear of pioneering radiosurgery treatments and knowledge-based planning techniques at two Varian-hosted symposia VIENNA, April
PALO ALTO, Calif., April 10, 2014 /PRNewswire/ -- Varian Medical Systems (NYSE:VAR) today is reporting that it has settled patent litigation with the University of Pittsburgh.
PALO ALTO, Calif.
Full range of equipment and software for the precision treatment of cancer exhibited at the Reed Messe Vienna Conference Center VIENNA, April 3, 2014 /PRNewswire/ -- Booths 2400/2800
PALO ALTO, Calif., April 3, 2014 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) announced today that its management will hold a mid-year review for investors from 11:30 a.m.
Clinicians at Humanitas Cancer Center in Milan among first in world to commence treatments using Edge radiosurgery system MILAN, Italy, April 2, 2014 /PRNewswire/ -- Humanitas Cancer
VIENNA, Austria, April 1, 2014 /PRNewswire/ -- Kaiser-Franz-Josef Hospital in Vienna has become one of the first oncology departments in Europe to introduce clinical treatments using
BERGISCH GLADBACH, Germany, March 31, 2014 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) and the Paul Scherrer Institute
DETROIT, March 27, 2014 /PRNewswire/ -- Patients at Henry Ford Hospital now have a new cancer treatment available that offers an alternative cancer surgery, without the incision or hospital stay, treating
- An imitative word; an onomatopoetic word.